Oramed Pharmaceuticals Inc
Biotechnology
Healthcare
ORMP
40.85 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.46
52 week high
2.62
high
2.50
52 week low
0.00
low
2.35
growth
7.79 %
previous Close
2.47
P/E ratio
market cap
88.24 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
382.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top